HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial ...
If you are managing chronic skin wounds or venous issues under Medicare, 2026 marks a turning point: the program has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results